Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum group I pepsinogens

H L Waldum, P G Burhol

    Scandinavian Journal of Gastroenterology
    |January 1, 1981
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Editorial: proton pump inhibitors (PPIs) and primary liver cancer.

    Alimentary pharmacology & therapeutics·2018
    Same author

    Letter: proton pump inhibitors, hypergastrinaemia and the risk of gastric neoplasia.

    Alimentary pharmacology & therapeutics·2015
    Same author

    The regulation of gastric acid secretion - clinical perspectives.

    Acta physiologica (Oxford, England)·2013
    Same author

    Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.

    Clinical and experimental immunology·2013
    Same author

    Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A.

    Alimentary pharmacology & therapeutics·2012
    Same author

    Gastric carcinoids after long-term use of a proton pump inhibitor.

    Alimentary pharmacology & therapeutics·2012